PRRX1 upregulates PD-L1 in human mesenchymal stem cells

Taro Osawa, Daisuke Yamada, Tomoko Takao, Lu Ming, Takeshi Takarada

Research output: Contribution to journalArticlepeer-review

Abstract

Mesenchymal stem cells (MSCs) have been demonstrated to be efficacious in clinical applications for the amelioration of immune disorders, including graft-versus-host disease (GvHD) and Crohn's disease. The immunosuppressive role of Programmed death-ligand 1 (PD-L1) in MSCs is pivotal, yet the regulatory mechanisms governing its expression remain to be fully elucidated. In this study, we explored the influence of paired-related homeobox (PRRX1), a determinant of multipotency and self-renewal in MSCs, on the expression of various surface antigens, notably PD-L1. Multiple isoforms of PRRX1 were found to augment the mRNA levels of MSC markers, such as CD26 and CD317, with all isoforms elevating PD-L1 expression at both mRNA and protein levels. This study reveals that PRRX1 may act as a potential immunomodulatory factor in MSCs by regulating the PD-L1 pathway.

Original languageEnglish
Article number102223
Pages (from-to)1132-1137
Number of pages6
JournalIn Vitro Cellular and Developmental Biology - Animal
Volume60
Issue number10
DOIs
Publication statusPublished - Dec 2024

Keywords

  • Immunomodulation
  • Mesenchymal stem cells
  • Paired-related homeobox 1
  • Programmed death-ligand 1

ASJC Scopus subject areas

  • Developmental Biology
  • Cell Biology

Fingerprint

Dive into the research topics of 'PRRX1 upregulates PD-L1 in human mesenchymal stem cells'. Together they form a unique fingerprint.

Cite this